mk 0591 has been researched along with Bright Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford-Hutchinson, A; Petric, R | 1 |
| Ford-Hutchinson, AW; Nicholson, DW; Petric, R | 1 |
| Badr, KF; Guasch, A; Zayas, CF | 1 |
3 other study(ies) available for mk 0591 and Bright Disease
| Article | Year |
|---|---|
Inhibition of leukotriene biosynthesis improves renal function in experimental glomerulonephritis.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Glomerulonephritis; Glutathione Transferase; Indoles; Kidney; Kidney Function Tests; Leukotrienes; Lipoxygenase Inhibitors; Male; Membrane Proteins; Microsomes; Proteinuria; Quinolines; Rats; Rats, Sprague-Dawley | 1995 |
Renal leukotriene C4 synthase: characterization, partial purification and alterations in experimental glomerulonephritis.
Topics: Animals; Cytosol; Glomerulonephritis; Glutathione; Glutathione Transferase; Indoles; Kidney Cortex; Kinetics; Leukotriene A4; Leukotriene C4; Male; Microsomes; Quinolines; Rats; Rats, Sprague-Dawley | 1995 |
MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.
Topics: Adult; Aged; Female; Glomerulonephritis; Humans; Indoles; Kidney Glomerulus; Lipoxygenase Inhibitors; Male; Middle Aged; Permeability; Pilot Projects; Proteinuria; Quinolines; Treatment Outcome | 1999 |